Ecolab USA Inc. has successfully secured the transfer of the disputed domain <ecolabs.info> from respondent Mckenna Cummerata. The respondent registered the domain to host a site offering injectable and oral hormone products, exploiting the brand’s association with industrial chemical resins. A WIPO panelist ruled the domain was registered and used in bad faith, ordering its immediate transfer.
Case Snapshot
| Case Number | D2025-5178 |
|---|---|
| Complainant | Ecolab USA Inc. |
| Respondent | Mckenna Cummerata |
| Disputed Domain | ecolabs.info |
| Threat Tactic | Typo Domains |
| Decision Date | 2026-01-29 |
| Panelist | Nicholas Weston |
| Outcome | Transfer |
| Official Source | https://www.wipo.int/amc/en/domains/search/text.jsp?case=D2025-5178 |
Severe Reputational and Commercial Exposures from Specialized Typosquatting
The registration and deployment of the pluralized domain <ecolabs.info> presents an acute traffic diversion and brand dilution risk to Ecolab USA Inc., a global enterprise with billions in annual sales across life sciences, energy, and healthcare. By adding a single letter ‘s’ to the distinctive ECOLAB trademark, the respondent exploited a classic typosquatting mechanism to capture and redirect digital traffic. For an organization operating in highly regulated B2B sectors, this unauthorized overlap threatens the integrity of its digital ecosystem, potentially siphoning off prospective clients, researchers, and industry partners who are seeking legitimate corporate channels but end up on an unauthorized digital property.
The business threat is amplified by the specific nature of the unauthorized content hosted on the disputed domain. The site purportedly offered injectable and oral hormone products—items that directly intersect with Ecolab’s business, as the company manufactures specialized resins used in these types of pharmaceutical preparations. This alignment creates a false impression of corporate affiliation, licensing, or endorsement. Even though there is no evidence verifying whether the displayed hormone products were counterfeit, dangerous, or actually shipped, the mere association of a major industrial and life sciences brand with unregulated medical sales online poses severe reputational risks that could undermine trust among corporate clients and regulatory bodies.
Beyond the immediate commercial impact, the bad-faith registration introduces systemic security and fraud risks. The respondent’s use of redacted and false registrar contact information, combined with an online storefront designed to pass itself off as affiliated with the complainant, establishes a prime vector for consumer deception. While the factual record does not show active email phishing campaigns or documented financial losses by Ecolab customers on this specific site, hosting a deceptive domain under a highly similar brand name creates an unacceptable vulnerability to data theft and fraudulent transactions, necessitating immediate UDRP corrective action.
Panel Evaluation of Confusing Similarity, Rights, and Bad Faith in the ecolabs.info Dispute
The evaluation of the first UDRP element by Panelist Nicholas Weston focused on the structural elements of the disputed domain name <ecolabs.info>. The panelist determined that the domain name is confusingly similar because it incorporates the complainant’s highly distinctive ECOLAB trademark in its entirety. The simple addition of the pluralizing letter ‘s’ and the generic Top-Level Domain (gTLD) ‘.info’ does not alter the commercial impression of the underlying mark or prevent confusing similarity. This finding aligns with established UDRP precedent regarding typosquatting, confirming that minor typographic alterations cannot shield a respondent from liability.
Regarding the second element of the Policy, the panelist found that the respondent, Mckenna Cummerata, lacks any rights or legitimate interests in the disputed domain. Ecolab USA Inc. established a prima facie case by demonstrating that it has never licensed, authorized, or consented to the respondent’s use of its protected ECOLAB marks. Because the respondent failed to submit a formal response or demonstrate any active preparations to use the domain for a bona fide offering of goods or services, the panelist concluded that none of the circumstances under paragraph 4(c) of the Policy were satisfied.
The bad faith analysis under the third element of the Policy was established by examining both the registration and active use of the domain name. The respondent resolved <ecolabs.info> to a website purportedly offering injectable and oral hormone products. Because the complainant manufactures specialized resins used in pharmaceutical preparations of this nature, the panelist observed a direct industry overlap that increased the risk of confusion. This use of the disputed domain was deemed an intentional attempt to pass the site off as sponsored by or affiliated with the complainant to exploit the goodwill of a global brand with billions in annual sales.
Finally, the panelist observed additional procedural indicators of bad faith, notably the respondent’s administrative conduct. The provision of false or redacted contact details during the registration process with Hostinger Operations, UAB, which required clarification during registrar verification, was cited as evidence of bad faith. This deceptive registration tactic, paired with the respondent’s default and failure to answer the allegations of passing off, confirmed a pattern of bad faith registration and use, leading the panel to order the transfer of the domain name.
Strategic Alignment of Trademark Precedent and Industry Overlap
The Complainant’s strategy succeeded by systematically establishing its longstanding trademark rights and directly linking the unauthorized domain’s content to its specialized B2B operations. Ecolab USA Inc. presented its foundational United States trademark registration for ECOLAB dating back to July 1988, alongside international registrations from 2009 covering multiple classes. This robust portfolio proved that the Complainant’s rights long predated the Respondent’s registration of <ecolabs.info> on July 27, 2025. By demonstrating that the disputed domain incorporated the ECOLAB mark in its entirety with merely the addition of a pluralizing "s" and the gTLD ".info", the Complainant left no room for the Respondent to claim a distinct identity, securing a clear finding of confusing similarity.
A highly persuasive element of the Complainant’s case was the evidentiary connection drawn between the Respondent’s storefront and Ecolab’s actual product lines. The disputed site offered injectable and oral hormone products, which directly intersect with the pharmaceutical-grade resins manufactured by Ecolab. By exposing this commercial overlap, the Complainant demonstrated that the Respondent was not merely hosting a random site, but was actively passing itself off as affiliated with Ecolab to divert traffic within a high-value industrial niche. This correlation, combined with proof of the Respondent’s redacted registrar contact details and subsequent failure to submit a response, solidified the finding of bad faith registration and use under the UDRP.
Practical Recommendations
- Proactively monitor and defensively register pluralized variations of core brands (such as adding an ‘s’ to a highly distinctive mark) across generic Top-Level Domains (gTLDs) like ‘.info’ to prevent typosquatting and traffic diversion.
- Establish and present a clear supply-chain connection when a disputed domain sells adjacent goods; demonstrating that the unauthorized products (e.g., hormones) rely on raw materials or industrial components manufactured by the brand owner (e.g., chemical resins) is highly effective for proving targeted bad faith.
- Identify and document discrepancies or clearly false/redacted contact information disclosed by the registrar during the UDRP verification process, and explicitly present these bad-faith registration tactics as evidence to the panel.
- Maintain a comprehensive, ready-to-file portfolio of global trademark registrations and historical domain ownership (such as ‘ecolab.com’ registered in 1996) to establish undisputed priority and easily defeat any claims of legitimate interest by newly registered domains.
Frequently Asked Questions (FAQ)
Why did the WIPO panel rule that <ecolabs.info> is confusingly similar to the ECOLAB trademark?
The Panel determined that the domain name incorporates the globally recognized ECOLAB trademark in its entirety. The simple addition of the letter ‘s’ and the ‘.info’ gTLD was deemed insufficient to distinguish the domain from the Complainant’s brand, creating a high risk of consumer confusion.
What evidence proved that the respondent lacked legitimate interests in the disputed domain?
The Complainant demonstrated that it never authorized, licensed, or consented to the Respondent’s use of the ECOLAB mark. Furthermore, the Respondent failed to respond to the allegations or provide any evidence of a legitimate non-commercial or fair use of the domain, leading the Panel to infer a lack of rights.
How was ‘bad faith’ established in the registration and use of the domain?
Bad faith was confirmed through the Respondent’s attempt to pass the site off as an affiliate of Ecolab to sell pharmaceutical products. This was compounded by the Respondent’s use of false or redacted contact information during the registration process, a practice frequently cited in UDRP proceedings as evidence of deceptive intent.
What was the practical business outcome of this UDRP filing?
The WIPO Panelist ordered the immediate transfer of <ecolabs.info> to Ecolab USA Inc. This successful action effectively halted the potential diversion of customers to an unauthorized storefront and mitigated the reputational risks associated with the illicit sale of hormone products under a domain confusingly similar to the Ecolab brand.
Need to recover a look-alike domain?
Don’t let pluralized variations or typosquatted domains siphon your traffic and impersonate your brand identity. Learn how to leverage UDRP proceedings to secure your digital perimeter.
This case note is for informational purposes only and is not legal advice.
